Structure |
Chemical Name |
CAS |
MF |
![1,8-bis(4-((1,4,8,11-tetraazacyclotetradecan-4,8,11-trifluoroacetyl- 1-yl)methyl)benzyl)-4,11-difluoroacetyl-1,4,8,11- tetraazacyclotetradecane](/) |
1,8-bis(4-((1,4,8,11-tetraazacyclotetradecan-4,8,11-trifluoroacetyl- 1-yl)methyl)benzyl)-4,11-difluoroacetyl-1,4,8,11- tetraazacyclotetradecane |
|
|
![Fulvestrant Impurity 4](/CAS/20211123/GIF/1621885-82-2.gif) |
Fulvestrant Impurity 4 |
1621885-82-2 |
C30H44O6S |
![Clopidogrel](/CAS/20200331/GIF/1360923-54-1.gif) |
Clopidogrel |
1360923-54-1 |
C16H16ClNO3S |
![Ozagrel-015](/CAS/20210111/GIF/1332370-00-9.gif) |
Ozagrel-015 |
1332370-00-9 |
C10H10O3 |
![Piperacillin Sulfoxide](/CAS/20210111/GIF/67275-27-8.gif) |
Piperacillin Sulfoxide |
67275-27-8 |
C23H27N5O8S |
![Budesonide Impurity 11](/CAS/20211123/GIF/39672-76-9.gif) |
Budesonide Impurity 11 |
39672-76-9 |
C21H26O5 |
![1,8-bis(4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl) benzyl)-1,4,8,11-tetraazacyclotetradecane dodecahydrochloride](/CAS/20200331/GIF/2173049-85-7.gif) |
1,8-bis(4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl) benzyl)-1,4,8,11-tetraazacyclotetradecane dodecahydrochloride |
2173049-85-7 |
C46H85ClN12 |
![Mirabegron Impurity 26](/CAS/20210111/GIF/91828-74-9.gif) |
Mirabegron Impurity 26 |
91828-74-9 |
C8H9N3O4 |
![2-(3-cyano-4-isobutoxyphenyl)-N,N,4-trimethylthiazole-5- carboxamide](/CAS/20200401/GIF/1380049-45-5.gif) |
2-(3-cyano-4-isobutoxyphenyl)-N,N,4-trimethylthiazole-5- carboxamide |
1380049-45-5 |
C18H21N3O2S |
![Oseltamivir Impurity 10](/CAS/20210305/GIF/2081110-43-0.gif) |
Oseltamivir Impurity 10 |
2081110-43-0 |
C16H28N2O4 |
![Pitavastatin Impurity 41](/) |
Pitavastatin Impurity 41 |
|
|
![Rivaroxaban Impurity 14](/CAS/20200611/GIF/1429334-02-0.gif) |
Rivaroxaban Impurity 14 |
1429334-02-0 |
C15H21N3O4 |
![Ticagrelor Impurity 69](/) |
Ticagrelor Impurity 69 |
|
|
![Tofacitinib Impurity 71](/) |
Tofacitinib Impurity 71 |
|
|
![Tofacitinib Impurity 79](/) |
Tofacitinib Impurity 79 |
|
|
![Topiroxostat Impurity 5](/CAS/20200611/GIF/2050015-91-1.gif) |
Topiroxostat Impurity 5 |
2050015-91-1 |
C7H6N4O |
![Canagliflozin-10](/CAS/20210111/GIF/2161394-94-9.gif) |
Canagliflozin-10 |
2161394-94-9 |
C24H25FO5S |
![2-amino-N-(2-methylphenyl)-5-thiazolecarboxamide](/CAS/20200401/GIF/1184914-03-1.gif) |
2-amino-N-(2-methylphenyl)-5-thiazolecarboxamide |
1184914-03-1 |
C11H11N3OS |
![Aztreonam Impurity 7](/) |
Aztreonam Impurity 7 |
|
|
![Canagliflozin Impurity 43](/) |
Canagliflozin Impurity 43 |
|
|
![Carvedilol Impurity 2](/CAS/20200611/GIF/1198090-71-9.gif) |
Carvedilol Impurity 2 |
1198090-71-9 |
C18H17NO3 |
![Clotrimazole Impurity 2](/) |
Clotrimazole Impurity 2 |
|
|
![Dapagliflozin Impurity 33](/) |
Dapagliflozin Impurity 33 |
|
|
![Erlotinib Impurity 56](/) |
Erlotinib Impurity 56 |
|
|
![Moxifloxacin Impurity 8](/CAS/20210111/GIF/1829588-19-3.gif) |
Moxifloxacin Impurity 8 |
1829588-19-3 |
C21H25N3O5 |
![Olaparib Impurity 30](/CAS/20210111/GIF/1460272-52-9.gif) |
Olaparib Impurity 30 |
1460272-52-9 |
C24H21FN4O4 |
![Pitavastatin Impurity 27](/) |
Pitavastatin Impurity 27 |
|
|
![Pramipexole Impurity 24](/) |
Pramipexole Impurity 24 |
|
|
![Rocuronium Bromide Impurity 22](/) |
Rocuronium Bromide Impurity 22 |
|
|
![Tolterodine Impurity 1](/CAS/20200331/GIF/CB54821015.gif) |
Tolterodine Impurity 1 |
88407-28-7 |
C22H31NO |
![Voriconazole Impurity 7](/CAS/20211123/GIF/239807-04-6.gif) |
Voriconazole Impurity 7 |
239807-04-6 |
C16H14F3N5O |
![AZD9291 Osimertinib Impurity 3](/) |
AZD9291 Osimertinib Impurity 3 |
|
|
![Dextrorotation lansoprazole Impurity K](/) |
Dextrorotation lansoprazole Impurity K |
|
|
![Doxofylline Impurity A](/) |
Doxofylline Impurity A |
|
|
![lansoprazole Impurity 24](/) |
lansoprazole Impurity 24 |
|
|
![lansoprazole Impurity 30](/) |
lansoprazole Impurity 30 |
|
|
![meta-dyhydroxy Sugammadex sodium Impurity 2](/) |
meta-dyhydroxy Sugammadex sodium Impurity 2 |
|
|
![Palbociclib Impurity 29](/) |
Palbociclib Impurity 29 |
|
|
![Palbociclib Impurity 34](/) |
Palbociclib Impurity 34 |
|
|
![Ropivacaine Impurity 38](/) |
Ropivacaine Impurity 38 |
|
|
![Ropivacaine Impurity 43](/) |
Ropivacaine Impurity 43 |
2726971-51-1 |
|
![Sugammadex sodium Decomposition process Impurity 1](/) |
Sugammadex sodium Decomposition process Impurity 1 |
|
|
![Sugammadex sodium Org198786-1 Impurity](/) |
Sugammadex sodium Org198786-1 Impurity |
|
|
![Sugammadex sodium starting material Impurity 1](/) |
Sugammadex sodium starting material Impurity 1 |
|
|
![Fludarabine EP impurity H](/CAS/20210111/GIF/548774-57-8.gif) |
Fludarabine EP impurity H |
548774-57-8 |
C10H10FN5O3 |
![Butyphthalide impurity 30](/) |
Butyphthalide impurity 30 |
|
|
![Cabozantinib impurity S](/) |
Cabozantinib impurity S |
|
|
![Ticagrelor Impurity 39](/) |
Ticagrelor Impurity 39 |
|
|
![Tofacitinib Impurity 109](/) |
Tofacitinib Impurity 109 |
|
|
![Tofacitinib Impurity 114](/) |
Tofacitinib Impurity 114 |
|
|
![Vildagliptin Impurity 34](/CAS/20210111/GIF/1824265-77-1.gif) |
Vildagliptin Impurity 34 |
1824265-77-1 |
C10H17NO3 |
![1-(3-(benzyloxy)-5-hydroxyphenyl)-2-(tert-butylamino)ethan-1-one](/CAS/20200331/GIF/CB54908512.gif) |
1-(3-(benzyloxy)-5-hydroxyphenyl)-2-(tert-butylamino)ethan-1-one |
2459974-72-0 |
C19H23NO3 |
![Demeclocycline EP Impurity C](/CAS/20210111/GIF/129044-45-7.gif) |
Demeclocycline EP Impurity C |
129044-45-7 |
C21H22N2O8 |
![Brimonidine Impurity D](/) |
Brimonidine Impurity D |
|
|
![Esmolol impurity D](/) |
Esmolol impurity D |
|
|
![Diquafosol Impurity D](/) |
Diquafosol Impurity D |
|
|
![Peramivir Impurity 11](/) |
Peramivir Impurity 11 |
|
|
![Vildagliptin Impurity 6](/) |
Vildagliptin Impurity 6 |
|
|
![Sunitinib Impurity 1](/) |
Sunitinib Impurity 1 |
|
|
![Erlotinib Impurity 18](/) |
Erlotinib Impurity 18 |
|
|
![Fasudil Impurity 6](/CAS/20211123/GIF/1581642-06-9.gif) |
Fasudil Impurity 6 |
1581642-06-9 |
C14H18ClN3O2S |
![Rosuvastatin Impurity 56](/) |
Rosuvastatin Impurity 56 |
|
|
![Dapoxetine Impurity 4](/) |
Dapoxetine Impurity 4 |
|
|
![Ticagrelor Impurity 17](/) |
Ticagrelor Impurity 17 |
|
|
![Empagliflozin Impurity 13](/) |
Empagliflozin Impurity 13 |
|
|
![Moxifloxacin Impurity 2](/) |
Moxifloxacin Impurity 2 |
|
|
![Cabozantinib Impurity 1](/) |
Cabozantinib Impurity 1 |
|
|
![Febuxostat Impurity 56](/) |
Febuxostat Impurity 56 |
|
|
![Ambroxol Impurity 9 HCl](/) |
Ambroxol Impurity 9 HCl |
|
|
![Penicillin Impurity A](/) |
Penicillin Impurity A |
|
|
![Cefminox Sodium impurity A](/) |
Cefminox Sodium impurity A |
|
|
![Cefotiam Impurity A](/) |
Cefotiam Impurity A |
|
|
![pranoprofen impurity 25](/) |
pranoprofen impurity 25 |
|
|
![Peramivir Impurity D](/) |
Peramivir Impurity D |
|
|
![Lincomycin sulfoxide Impurity 2](/) |
Lincomycin sulfoxide Impurity 2 |
|
|
![Lincomycin sulfoxide Impurity E](/) |
Lincomycin sulfoxide Impurity E |
|
|
![Fasudil iMpurity E](/) |
Fasudil iMpurity E |
|
|
![(+/-)-EPINEPHRINE SULFONIC ACID](/CAS/GIF/26405-77-6.gif) |
(+/-)-EPINEPHRINE SULFONIC ACID |
26405-77-6 |
C9H13NO5S |
![GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT)](/CAS/20180808/GIF/112188-16-6.gif) |
GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT) |
112188-16-6 |
C14H22GdN4O6 |
![((R)-2-biphenyl-4-yl-1-forMylethyl)carbaMic acid t-butyl ester](/CAS/20150408/GIF/149709-58-0.gif) |
((R)-2-biphenyl-4-yl-1-forMylethyl)carbaMic acid t-butyl ester |
149709-58-0 |
C20H23NO3 |
![1-(2,3-DiMethylphenyl)-1-(1H-iMidazol-4-yl)ethanol](/CAS/20150408/GIF/86347-12-8.gif) |
1-(2,3-DiMethylphenyl)-1-(1H-iMidazol-4-yl)ethanol |
86347-12-8 |
C13H16N2O |
![(R)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one](/CAS/20150408/GIF/CB72735602.gif) |
(R)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
1612153-32-8 |
C20H20FNO4 |
![(S)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one](/CAS/20150408/GIF/528565-93-7.gif) |
(S)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
528565-93-7 |
C20H20FNO4 |
![Posaconazole iMpurity 3](/) |
Posaconazole iMpurity 3 |
|
|
![Bezafibrate Impurity D](/CAS/20210111/GIF/41859-58-9.gif) |
Bezafibrate Impurity D |
41859-58-9 |
C21H24ClNO4 |
![Cloxacillin Sodium EP Impurity B (Mixture of Diastereomers)](/CAS/20200611/GIF/1642559-64-5.gif) |
Cloxacillin Sodium EP Impurity B (Mixture of Diastereomers) |
1642559-64-5 |
C18H20ClN3O4S |
![Ezetimibe Related Impurity 37](/CAS/20200611/GIF/204589-68-4.gif) |
Ezetimibe Related Impurity 37 |
204589-68-4 |
C24H19F2NO2 |
![S, R-Isovalganciclovir Impurity](/CAS/20180808/GIF/1356932-18-7.gif) |
S, R-Isovalganciclovir Impurity |
1356932-18-7 |
C14H22N6O5 |
![Sofosbuvir Impurity 8](/CAS/20200611/GIF/944476-44-2.gif) |
Sofosbuvir Impurity 8 |
944476-44-2 |
C24H22N2O8 |
![1-((2'-cyanobiphenyl-4-yl)methyl)-4-methyl-2-propyl-1H-benzo[d]imidazole-6-carboxylic acid](/CAS/20180703/GIF/1098100-87-8.gif) |
1-((2'-cyanobiphenyl-4-yl)methyl)-4-methyl-2-propyl-1H-benzo[d]imidazole-6-carboxylic acid |
1098100-87-8 |
C26H23N3O2 |
![Fimasartan Impurity](/) |
Fimasartan Impurity |
|
|
![2-(((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methyl)(methyl)amino)succinic acid](/CAS/20180703/GIF/CB72750072.gif) |
2-(((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methyl)(methyl)amino)succinic acid |
|
C21H20FN3O6S |
![2-(DIETHYLAMINO)-N-(2,4-DIMETHYLPHENYL)ACETAMIDE](/CAS/20180703/GIF/17289-53-1.gif) |
2-(DIETHYLAMINO)-N-(2,4-DIMETHYLPHENYL)ACETAMIDE |
17289-53-1 |
C14H22N2O |
![(3RS)-3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one](/CAS/20180703/GIF/CB72920112.gif) |
(3RS)-3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one |
|
C16H20N2O |
![Oxaliplatin impurity](/) |
Oxaliplatin impurity |
|
|
![NiMesulide EP IMpurity](/CAS/20200515/GIF/38880-53-4.gif) |
NiMesulide EP IMpurity |
38880-53-4 |
C7H8N2O5S |
![Moxifloxacin Impurities](/) |
Moxifloxacin Impurities |
|
|
![Parecoxib Impurity K](/CAS/20200611/GIF/198471-69-1.gif) |
Parecoxib Impurity K |
198471-69-1 |
C17H16N2O3S |
![Linagliptin Impurity K](/CAS/20200611/GIF/1638744-06-5.gif) |
Linagliptin Impurity K |
1638744-06-5 |
C25H29BrN8O2 |
![(R)-2-((6-(3-((3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile](/CAS/20180703/GIF/CB73042202.gif) |
(R)-2-((6-(3-((3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile |
1917324-13-0 |
C31H28F2N8O4 |